EN
HI
Sandu Pharmaceuticals share price chart
Sandu Pharmaceuticals Share Key Metrics
Volume
2147.00
Market Cap
35.71 CR
LTQ@LTP
3@36.96
ATP
37.94
Var Margin
25 %
Circuit Range
29.02-43.52
Delivery %
81.04 %
Value
81457.18
ASM/GSM
No
Market Lot
1
Summary
SANDUPHQ stock price is ₹36.96 as of 14 Aug, 2026. The stock intraday movement has stayed between ₹36.63 and ₹39.85, while Sandu Pharmaceuticals share price 52 week high low is ₹30.00 & ₹51.00.
In terms of trading activity, SANDUPHQ share price has recorded a volume of 2,147 shares. The Sandu Pharmaceuticals has a market cap of ₹9660990. The stock’s Average Traded Price (ATP) stands at ₹37.94, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹36.96.
The Sandu Pharmaceuticals upper circuit limit is ₹43.52 & The Sandu Pharmaceuticals lower circuit limit is ₹29.02, with a Value of ₹81457.18. The Delivery Percentage for the day is 81.04%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Sandu Pharmaceuticals Fundamentals
P/E Ratio
22.58
P/B Ratio
1.05
Div. Yield
2.76
Sector P/E
64.91
Sector P/B
3.33
Sec. Div. Yield
0.51
Sandu Pharmaceuticals Resistance and Support
Pivot 36.53
Resistance
First Resistance
39.41
Second Resistance
42.56
Third Resistance
45.44
Support
First Support
33.38
Second Support
30.5
Third Support
27.35
Sandu Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 14 2026 | 39.85 | 36.96 | 1.90% | 39.85 | 36.63 |
| Thu Aug 13 2026 | 39.68 | 36.27 | -7.69% | 39.68 | 33.65 |
| Wed Aug 12 2026 | 39.84 | 39.29 | -0.41% | 40.29 | 37.79 |
Sandu Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-07-11 | Others |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-12 | Quarterly Results & Final Dividend |
Sandu Pharmaceuticals News
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sandu Pharmaceuticals' 41st Annual General Meeting (AGM) is scheduled for September 11, 2026, at 04:30 PM via electronic mode. Key agenda item includes considering the Board's recommendation of a Rs.1.00 dividend per equity share for FY26.
Aug 14 2026 12:24:29
Sandu Pharmaceuticals Ltd - 524703 - Approval Of Material Related Party Transactions Subject To Approval Of Shareholders
Sandu Pharma's board approved Q1 FY27 standalone financial results, with revenue of Rs.16.39 cr and net profit of Rs.0.23 cr. The board also recommended a new statutory auditor and related party transactions, and fixed September 4, 2026, as the record date for the FY26 dividend.
Aug 11 2026 18:41:49
Read More
Sandu Pharmaceuticals Management
| Name | Position |
|---|---|
| Balram Viswanathan | Chairman & Non Executive Independent Director |
| Ajit R Kantak | Non Executive Independent Director |
Sandu Pharmaceuticals Similar Stocks
Vivimed Labs Ltd.
4.93
-0.06 (1.20%)
Family Care Hospitals Ltd.
1.91
-0.41 (17.67%)
ANG Lifesciences India Ltd.
31.42
0.00 (0.00%)
Global Longlife Hospital and Research Ltd.
11.84
0.04 (0.34%)
Phaarmasia Ltd.
77.01
-7.57 (8.95%)
Adeshwar Meditex Ltd.
16.80
0.50 (3.07%)
KK Shah Hospitals Ltd.
43.90
0.00 (0.00%)
Bandaram Pharma Packtech Ltd.
18.05
-0.64 (3.42%)
Panjon Ltd.
19.10
-0.43 (2.20%)
Deccan Health Care Ltd.
12.81
-0.67 (4.97%)
Sandu Pharmaceuticals FAQs
The Buying Price of Sandu Pharmaceuticals share is 36.96 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sandu Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sandu Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sandu Pharmaceuticals shares is 22.58. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sandu Pharmaceuticals shares is 1.05. Useful to assess the stock's value relative to its book value.
To assess Sandu Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.91 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sandu Pharmaceuticals is 35.71 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sandu Pharmaceuticals share price is 51.00 & 30.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sandu Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
